English
简体中文
Total: £ 56.28
2026-03-24 | Pages: 97 | Tables: 99
The global Meningococcal Group A and C Conjugate Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the g...
2026-03-24 | Pages: 115 | Tables: 112
The global Ferrous Sulfate Oral Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-24 | Pages: 125 | Tables: 125
The global Iron Supplement Oral Solution market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-24 | Pages: 125 | Tables: 127
The global Liquid Pet Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape...
2026-03-24 | Pages: 93 | Tables: 107
The global Oral Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-03-24 | Pages: 90 | Tables: 94
The global Live Attenuated Rotavirus Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econom...
2026-03-24 | Pages: 122 | Tables: 120
The global Anemia Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-03-24 | Pages: 97 | Tables: 91
The global Cefprozil Granules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-03-24 | Pages: 100 | Tables: 107
The global Cefprozil Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. T...
2026-03-24 | Pages: 117 | Tables: 115
The global Cefprozil Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. Th...
2026-03-24 | Pages: 99 | Tables: 104
The global Peripheral Liquid Embolic Agents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economi...
2026-03-24 | Pages: 139 | Tables: 139
The global Pet Joint Care Supplements market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic land...
2026-03-24 | Pages: 92 | Tables: 94
The global Anti-polyomavirus Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The North American market for Anti-polyomavirus Drugs is projected to increase from US$ milli...
2026-03-24 | Pages: 120 | Tables: 124
The global Zolmitriptan Preparations market was valued at US$ 257 million in 2025 and is anticipated to reach US$ 353 million by 2032, at a CAGR of 4.8% from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global ec...
2026-03-24 | Pages: 111 | Tables: 118
The global iPSC Therapy market was valued at US$ 89.67 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 11.3% from 2026 to 2032.iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine...
